First National Bank of South Miami’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PF
APF
First National Bank of South Miami's XBI Position: Q2 2023 in Review
First National Bank of South Miami reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 25% in Q2 2023, selling an estimated $9.62K and leaving 345 shares worth $28.7K. The position accounts for 0.02% of the portfolio, ranked #196.
First National Bank of South Miami first reported a position in XBI in Q4 2018 and has held it in 19 quarters since. The position peaked at $65K in Q4 2020. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.
- First National Bank of South Miami held 345 shares of State Street SPDR S&P Biotech ETF worth $28.7K as of Q2 2023.
- First National Bank of South Miami sold 115 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $9.62K.
- State Street SPDR S&P Biotech ETF made up 0.02% of First National Bank of South Miami's portfolio in Q2 2023, its #196 holding.
- First National Bank of South Miami first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 19 quarters since.
- First National Bank of South Miami's State Street SPDR S&P Biotech ETF position peaked at $65K in Q4 2020.
- 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.
Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.